Therefore, our findings identify the molecular mechanism by which ET-1 axis controls HIF-1α stabilization through the involvement of PHD2 degradation pathway, providing further support to the notion that ETBR blockade may offer a potential tool for melanoma treatment. Here, EGLN1 is linked to melanoma.